MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00392-024-02551-x

Медицинская библиотека · Clinical research in cardiology : official journal of the German Cardiac Society · 2024

Ventilation strategies in cardiogenic shock: insights from the FRENSHOCK observational registry.

Volle Kim, Merdji Hamid, Bataille Vincent, Lamblin Nicolas, Roubille François, Levy Bruno, Champion Sebastien, Lim Pascal, Schneider Francis, Labbe Vincent, Khachab Hadi, Bourenne Jeremy, Seronde Marie-France, Schurtz Guillaume, Harbaoui Brahim, Vanzetto Gerald, Quentin Charlotte, Combaret Nicolas, Marchandot Benjamin, Lattuca Benoit, Biendel Caroline, Leurent Guillaume, Bonello Laurent, Gerbaud Edouard, Puymirat Etienne, Bonnefoy Eric, Aissaoui Nadia, Delmas Clément, FRENSHOCK Investigator

СтатьяНаблюдательное исследованиеМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

Despite scarce data, invasive mechanical ventilation (MV) is widely suggested as first-line ventilatory support in cardiogenic shock (CS) patients. We assessed the real-life use of different ventilation strategies in CS and their influence on short and mid-term prognosis.

METHODS

FRENSHOCK was a prospective registry including 772 CS patients from 49 centers in France. Patients were categorized into three groups according to the ventilatory supports during hospitalization: no mechanical ventilation group (NV), non-invasive ventilation alone group (NIV), and invasive mechanical ventilation group (MV). We compared clinical characteristics, management, and occurrence of death and major adverse event (MAE) (death, heart transplantation or ventricular assist device) at 30 days and 1 year between the three groups.

RESULTS

Seven hundred sixty-eight patients were included in this analysis. Mean age was 66 years and 71% were men. Among them, 359 did not receive any ventilatory support (46.7%), 118 only NIV (15.4%), and 291 MV (37.9%). MV patients presented more severe CS with more skin mottling, higher lactate levels, and higher use of vasoactive drugs and mechanical circulatory support. MV was associated with higher mortality and MAE at 30 days (HR 1.41 [1.05-1.90] and 1.52 [1.16-1.99] vs NV). No difference in mortality (HR 0.79 [0.49-1.26]) or MAE (HR 0.83 [0.54-1.27]) was found between NIV patients and NV patients. Similar results were found at 1-year follow-up.

CONCLUSIONS

Our study suggests that using NIV is safe in selected patients with less profound CS and no other MV indication. NCT02703038.

Для цитирования: Volle Kim, Merdji Hamid, Bataille Vincent, Lamblin Nicolas, Roubille François, Levy Bruno, Champion Sebastien, Lim Pascal, Schneider Francis, Labbe Vincent, Khachab Hadi, Bourenne Jeremy, Seronde Marie-France, Schurtz Guillaume, Harbaoui Brahim, Vanzetto Gerald, Quentin Charlotte, Combaret Nicolas, Marchandot Benjamin, Lattuca Benoit, Biendel Caroline, Leurent Guillaume, Bonello Laurent, Gerbaud Edouard, Puymirat Etienne, Bonnefoy Eric, Aissaoui Nadia, Delmas Clément, FRENSHOCK Investigator. Ventilation strategies in cardiogenic shock: insights from the FRENSHOCK observational registry.. Clinical research in cardiology : official journal of the German Cardiac Society. 2024. DOI: 10.1007/s00392-024-02551-x.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.